Prostate Carcinoma: Clinical Trials

6 trials for Prostate Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 active not recruiting, 2 recruiting, 1 not yet recruiting. 6 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Active not recruiting 3, Recruiting 2, Not yet recruiting 1
Phase 21Active not recruiting 1

Follow Prostate Carcinoma: new trials by email Literature Review of Prostate Carcinoma trials Research Report on Prostate Carcinoma

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Multiparametric Ultrasound for the Diagnosis of Clinically Significant Prostate Cancer
ultiparametric Magnetic Resonance Imaging, Perflutren lipid microsphere, Transrectal Ultrasound - Prostate Carcinoma
Phase 3Not yet recruitingThomas Jefferson University3002026-10-012026-08-25
Radiation Therapy With RapidPlan Knowledge-based Planning vs Human-Driven Planning for Treatment of Prostate Cancer
Biospecimen Collection, Magnetic Resonance Imaging, Photon Beam Radiation Therapy - Prostate Carcinoma
Phase 3RecruitingMayo Clinic1082025-02-022026-10-02
Low-Intensity Extracorporeal Shockwave Therapy on Penile Rehabilitation After Robot-assisted Surgical Treatment of Genitourinary Cancers
Low-intensity Extracorporeal Shock Wave Therapy (LiESWT), PDE5 inhibitor (tadalafil) - Prostate Carcinoma, Erectile Function
Phase 3RecruitingRegina Elena Cancer Institute1582023-09-152026-08-14
Prostate Cancer Diagnosis by Multiparametric Ultrasound (Wholemount)
Perflutren Lipid Microspheres, Ultrasound - Prostate Carcinoma
Phase 3Active not recruitingThomas Jefferson University702022-06-152025-09-04
Testing the Addition of Darolutamide to Hormonal Therapy (Androgen Deprivation Therapy [ADT]) After Surgery for Men With High-Risk Prostate Cancer, The ERADICATE Study
Darolutamide, Goserelin Acetate, Leuprolide Acetate - Prostate Carcinoma
Phase 3Active not recruitingECOG-ACRIN Cancer Research Group272021-03-012026-07-28
Methylphenidate and Exercise in Reducing Cancer-Related Fatigue in Patients With Prostate Cancer
Exercise Intervention, Methylphenidate, Placebo - Prostate Carcinoma
Phase 2 / Phase 3Active not recruitingM.D. Anderson Cancer Center2002019-03-252026-11-04

Narrower conditions

Prostatic Neoplasms (6)  ·  Urogenital Neoplasms (1)

Broader conditions

Genital Diseases (6)  ·  Genital Diseases, Male (6)  ·  Genital Neoplasms, Male (6)  ·  Male Urogenital Diseases (6)  ·  Neoplasms (6)  ·  Neoplasms by Site (6)  ·  Prostatic Diseases (6)  ·  Urogenital Diseases (6)  ·  Urogenital Neoplasms (5)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)

Interventions

perflutren (2)  ·  Goserelin (1)  ·  High-Energy Shock Waves (1)  ·  Leuprolide (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Methylphenidate (1)  ·  Phosphodiesterase 5 Inhibitors (1)  ·  Photons (1)  ·  Radiation (1)  ·  Specimen Handling (1)  ·  Tadalafil (1)  ·  Triptorelin Pamoate (1)  ·  Ultrasound, High-Intensity Focused, Transrectal (1)  ·  darolutamide (1)  ·  luprolide acetate gel depot (1)

Sponsors

Thomas Jefferson University (2)  ·  ECOG-ACRIN Cancer Research Group (1)  ·  M.D. Anderson Cancer Center (1)  ·  Mayo Clinic (1)  ·  Regina Elena Cancer Institute (1)

Countries

United States (5)  ·  Netherlands (2)  ·  Italy (1)

Top investigators

Alicia K Morgans (1)  ·  Nathan Y. Yu, MD (1)  ·  Sriram Yennu, MD (1)

NIH funding

R01CA252311 (1), U10CA180820 (1)